Navigation Links
Winners of 2017 Nobel Prize in Chemistry Helped Spark "New Era" in Biochemistry
Date:10/7/2017

WALTHAM, Mass., Oct. 6, 2017 /PRNewswire/ -- The 2017 Nobel Prize in Chemistry recognizes the pioneering work of three scientists, Jacques Dubochet, Joachim Frank and Richard Henderson, whose breakthrough developments in cryo-electron microscopy (cryo-EM) have helped to broaden the use of this technology within the structural biology community. The winners worked with systems manufactured by Thermo Fisher Scientific. Scientists can now routinely produce highly resolved, three-dimensional images of protein structures that lead to a better understanding of biological function and, ultimately, the development of new therapies.

Winners of 2017 Nobel Prize in Chemistry Helped Spark "New Era" in Cryo-EM
Winners of 2017 Nobel Prize in Chemistry Helped Spark "New Era" in Cryo-EM

According to the Nobel committee's announcement, cryo-EM has moved biochemistry into "a new era" where it's "now facing an explosive development and is all set for an exciting future." The work of the three winners spans decades, and their individual contributions helped spark follow-on efforts internationally that comprise a broad effort to bring cryo-EM to a wider scientific research community.

"The fact that cryo-EM technology is now in the hands of more scientists is a testament to the accomplishments of the scientific community over decades," said Mike Shafer, president, materials and structural analysis, Thermo Fisher Scientific. "The 2017 Nobel winners deserve recognition for filling in major pieces of the molecular mechanics puzzle. Thermo Fisher is committed to ongoing innovation to ensure that even more scientists, especially structural biologists, benefit from this game-changing technology."

Thermo Fisher gained its industry-leading cryo-EM capabilities through the 2016 acquisition of FEI Company, and it continues to expand the platform to make the analysis of proteins, protein complexes and other biomolecular structures faster, easier and more accessible to scientists. The company is using its scale and global reach to further accelerate the adoption of cryo-EM across the field of structural biology, where new advancements have made this an increasingly important technology.

About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with revenues of more than $20 billion and approximately 65,000 employees globally. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics, deliver medicines to market and increase laboratory productivity. Through our premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services – we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive services. For more information, please visit www.thermofisher.com.

Media Contact Information:

Ron O'Brien  
Phone: 781-622-1242 
E-mail:  ron.obrien@thermofisher.com
Website: www.thermofisher.com

Investor Contact Information:

Ken Apicerno
Phone: 781-622-1294
E-mail:  ken.apicerno@thermofisher.com

 

View original content with multimedia:http://www.prnewswire.com/news-releases/winners-of-2017-nobel-prize-in-chemistry-helped-spark-new-era-in-biochemistry-300532707.html


'/>"/>
SOURCE Thermo Fisher Scientific Inc.
Copyright©2017 PR Newswire.
All rights reserved


Related biology technology :

1. FierceBiotech Reveals the Fierce 15 Winners of 2017
2. Avomeen Selects 3rd Annual 2017 Science Student Scholarship Program Winners
3. DuPont and ADM Named Winners of 2017 Innovation in Bioplastics Award for Bio-Based Molecule Technology
4. ACEA Biosciences Announces Winners of its Travel Award
5. FierceMarkets Announces Winners of Fierce Innovation Awards: Life Sciences Edition
6. Global Supply Chain Resiliency Council Names 2016 Award Winners
7. ISPE Announces 2016 Facility of the Year Award Winners
8. ASAE Foundation Names Innovation Grants Program Award Winners
9. Blueline Bioscience announces milestone achievement by all Blueline Drug Target Program grant winners
10. California Dream Flight Sweepstakes Winners Chosen
11. Amgen And LabCentral Announce 2015 Golden Ticket Winners
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/27/2018)... ... September 27, 2018 , ... Global molecular diagnostics company, ... Holotype HLA and other Omixon products will be featured among nine posters produced ... Histocompatibility and Immunogenetics (ASHI) in Baltimore, MD. Additionally, Omixon’s Lunch Symposium ...
(Date:9/22/2018)... ... September 20, 2018 , ... Catalent Pharma Solutions, the leading ... consumer health products, today announced that it will be co-hosting a workshop with ... Development,”. The one-day event is to be held at the Hilton Boston Back ...
(Date:9/15/2018)... , ... September 14, 2018 , ... Nationally recognized public ... G. Patrick, CPA , Managing Partner of the Firm’s Nashville practice, on her appointment ... Bekaert since 2009 and was named Managing Partner of the Firm’s Nashville practice ...
(Date:9/12/2018)... ... September 11, 2018 , ... Leading regenerative veterinary medicine ... Practitioners Conference (AAFP) later this month. The company’s CEO and founder, ... the treatment of chronic kidney disease in felines at a poster session on ...
Breaking Biology Technology:
(Date:10/11/2018)... ... October 11, 2018 , ... Better lives through a ... for Innovation in Manufacturing Biopharmaceuticals (NIIMBL). The Institute, a public-private partnership launched in ... and workforce development in the United States. Biopharmaceuticals are important because they treat ...
(Date:10/5/2018)... ... ... EDETEK, the premier provider of digital clinical trial platforms, today announced that the ... 8-12, 2018. EDETEK is also a Gold Sponsor of the Bay-area Biotech (pharma) Statistics ... are global events held annually on three continents with hundreds of attendees gathering to ...
(Date:10/3/2018)... ... October 03, 2018 , ... ... discovery, development and commercialization of first-in-class stromal cell immunotherapies, announced that ORBCEL-M™, ... with type 2 diabetes and progressive diabetic kidney disease in a four-site, ...
Breaking Biology News(10 mins):